Mawer Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-61,966
| Closed | -$25.5M | – | 113 |
|
|
2022
Q1 | $25.5M | Sell |
61,966
-16,073
| -21% | -$6.6M | 0.12% | 78 |
|
|
2021
Q4 | $36.6M | Sell |
78,039
-16,753
| -18% | -$7.86M | 0.16% | 78 |
|
|
2021
Q3 | $40.2M | Sell |
94,792
-23
| -0% | -$9.76K | 0.19% | 78 |
|
|
2021
Q2 | $34M | Sell |
94,815
-38,772
| -29% | -$13.9M | 0.17% | 79 |
|
|
2021
Q1 | $37.6M | Buy |
133,587
+252
| +0.2% | +$71K | 0.2% | 76 |
|
|
2020
Q4 | $37.8M | Sell |
133,335
-289
| -0.2% | -$81.9K | 0.22% | 73 |
|
|
2020
Q3 | $36.7M | Sell |
133,624
-24,885
| -16% | -$6.84M | 0.24% | 67 |
|
|
2020
Q2 | $36M | Sell |
158,509
-23,023
| -13% | -$5.23M | 0.27% | 60 |
|
|
2020
Q1 | $27.6M | Sell |
181,532
-27,110
| -13% | -$4.13M | 0.25% | 62 |
|
|
2019
Q4 | $31.4M | Sell |
208,642
-16,116
| -7% | -$2.42M | 0.25% | 61 |
|
|
2019
Q3 | $31.9M | Sell |
224,758
-71,667
| -24% | -$10.2M | 0.29% | 59 |
|
|
2019
Q2 | $37.1M | Buy |
296,425
+6,200
| +2% | +$776K | 0.24% | 74 |
|
|
2019
Q1 | $32M | Sell |
290,225
-140
| -0% | -$15.4K | 0.23% | 69 |
|
|
2018
Q4 | $28.5M | Sell |
290,365
-23,435
| -7% | -$2.3M | 0.24% | 71 |
|
|
2018
Q3 | $38.7M | Buy |
313,800
+900
| +0.3% | +$111K | 0.29% | 68 |
|
|
2018
Q2 | $31.1M | Buy |
312,900
+39,094
| +14% | +$3.88M | 0.25% | 73 |
|
|
2018
Q1 | $24.2M | Buy |
273,806
+247,541
| +942% | +$21.9M | 0.2% | 77 |
|
|
2017
Q4 | $2.59M | Sell |
26,265
-20
| -0.1% | -$1.97K | 0.02% | 108 |
|
|
2017
Q3 | $2.53M | Buy |
+26,285
| New | +$2.53M | 0.02% | 104 |
|